Overview
The 5-FAM cadaverine, scientifically known as Fluorescein-5-carboxamide cadaverine, is a superior building block for researchers looking to prepare fluorescent ligands specifically for receptor binding assays. This compound stands out for its enhanced stability compared to traditional FITC reagents, making it an excellent choice for those engaged in precise experimental designs.
Key Features
- High stability, reducing hydrolysis compared to FITC bioconjugates
- Less stringent reaction conditions for better conjugation yields
- Ideal for receptor binding assays and other bioconjugation applications
- Available in a convenient 10 mg volume
- Part of our extensive range of green fluorescent labeling dyes
Specifications
| Product Name | 5-FAM cadaverine |
| CAS Number | Not available |
| Color | Green |
| Fluorescent Range | 500 – 550 nm |
| Weight | 10 mg |
FAQ
What applications is 5-FAM cadaverine suitable for?
5-FAM cadaverine is primarily used in receptor binding assays and other bioconjugation processes where fluorescent labeling is essential. Its stability makes it particularly valuable for long-duration experiments.
How does 5-FAM cadaverine compare to FITC reagents?
Unlike FITC reagents, which are known to have low stability and can undergo hydrolysis, 5-FAM cadaverine generates more resilient carboxamide bonds. This leads to improved conjugate stability and better overall results.
Can I find other fluorescent labeling dyes in your catalog?
Absolutely! We offer a variety of fluorescent labeling dyes, including options like 6-FAM and 6-FAM, SE. Browse our collection to discover the perfect dye for your research needs.
For researchers seeking reliable and stable fluorescent labeling solutions, the 5-FAM cadaverine is the ideal choice. Purchase your 10 mg vial today and enhance your experiments with this powerful compound.



![5-FAM cadaverine [Fluorescein-5-carboxamide cadaverine] - 10 mg](https://anaspecstore.com/wp-content/uploads/2026/10/as-81502-img-en-as-81502-01.jpg)
Reviews
There are no reviews yet.